Regen BioPharma (RGBP) News Today $0.08 +0.00 (+5.19%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerateNovember 28, 2024 | finanznachrichten.deRegen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate(TM)November 21, 2024 | stockhouse.comRegen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™November 19, 2024 | globenewswire.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern TimeSeptember 23, 2024 | globenewswire.comRegeneron Pharmaceuticals, Inc. (REGN): The Best Biotech Stock According to Hedge Funds?September 8, 2024 | msn.comRegen BioPharma Inc (RGBP)August 31, 2024 | investing.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024May 7, 2024 | finance.yahoo.comPresenting on the Emerging Growth Conference 69 Day 2 on April 4 Register NowApril 3, 2024 | finance.yahoo.comRegen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024April 2, 2024 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024March 5, 2024 | finance.yahoo.comRGBPP Regen BioPharma, Inc. PFD SER A NEWMarch 1, 2024 | seekingalpha.comRegen BioPharma Stock (OTC:RGBP) Earnings Dates and Earning CallsFebruary 25, 2024 | benzinga.comRegen BioPharma Stock (OTC:RGBP), Short Interest ReportFebruary 24, 2024 | benzinga.comRegen Biopharma Files Patent for Blood Recovery TreatmentFebruary 10, 2024 | msn.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024February 5, 2024 | finance.yahoo.comPresenting on the Emerging Growth Conference 66 Day 1 on January 10 Register NowJanuary 9, 2024 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024January 8, 2024 | finance.yahoo.comYeovil Refresh team asks for patience over town regenerationDecember 29, 2023 | bbc.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023December 5, 2023 | finance.yahoo.comRegen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR ExperimentsNovember 16, 2023 | finance.yahoo.comRegen BioPharma, Inc. CEO Outlines Future Steps in CAR T ProgramNovember 14, 2023 | finance.yahoo.comRegen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023October 30, 2023 | finance.yahoo.comRegen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy ProgramOctober 25, 2023 | finance.yahoo.comRegen BioPharma, Inc. Expects Second Phase of Confirmatory Study ShortlyOctober 18, 2023 | finance.yahoo.comRegen BioPharma, Inc. Receives First Phase of Confirmatory StudyOctober 10, 2023 | finance.yahoo.comGoldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.October 4, 2023 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on October 5, 2023October 3, 2023 | finance.yahoo.comRegen BioPharma Inc. Non-Cum. Pfd. Series ASeptember 21, 2023 | barrons.comStudies On Regen BioPharma, Inc.'s DURACAR Indicate Potential Suppression Of Autoimmunity, Company Retains Contract Research Organization To Conduct Additional Confirmatory StudiesSeptember 19, 2023 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023September 6, 2023 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on August 10, 2023August 8, 2023 | finance.yahoo.comCase study - urban regeneration in Stratford, LondonMarch 23, 2023 | bbc.co.ukRegen BioPharma, Inc. to Present at the Emerging Growth Conference on March 3, 2023March 7, 2023 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on February 22, 2023February 21, 2023 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on February 8, 2023February 7, 2023 | prnewswire.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on January 25, 2023January 23, 2023 | prnewswire.comRegen BioPharma Leverages Exosome Technologies to Broaden its Survivin Cancer Immunotherapy PortfolioJanuary 20, 2023 | finance.yahoo.comPresenting on the Emerging Growth Conference on January 11 Register NowJanuary 10, 2023 | finance.yahoo.comRegen BioPharma, Inc. to address 2023 goals and company direction at the Emerging Growth Conference on January 11, 2023January 9, 2023 | prnewswire.comRegen BioPharma, Inc. issues Message to the Shareholders from the Chairman And Chief Executive OfficerDecember 19, 2022 | finance.yahoo.comRegen BioPharma Appoints Two New Scientific Advisory Board MembersDecember 7, 2022 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on November 30, 2022November 28, 2022 | finance.yahoo.comRegen BioPharma, Inc. Progresses Its DuraCAR TherapeuticNovember 18, 2022 | finance.yahoo.comRegen BioPharma Developing a Non-Exhaustible CAR-T Cell TherapeuticNovember 10, 2022 | finance.yahoo.comRegen BioPharma, Inc. to Present at the Emerging Growth Conference on November 9, 2022November 2, 2022 | finance.yahoo.comRegen BioPharma, Inc. Explores the CAR-T Therapeutic SpaceOctober 26, 2022 | benzinga.comRegen BioPharma, Inc. Explores the CAR-T Therapeutic SpaceOctober 26, 2022 | finance.yahoo.comRegen BioPharma, Inc. Files Provisional Patent on CAR-T Cell Capable of Attracting and Educating Naive T Cells to Kill CancerOctober 7, 2022 | marketwatch.comGeoff Fordham obituaryOctober 6, 2022 | theguardian.comRegen BioPharma, Inc. Files Provisional Patent on CAR-T Cell Capable of Attracting and Educating Naïve T Cells to Kill CancerOctober 5, 2022 | benzinga.com Get Regen BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RGBP and its competitors with MarketBeat's FREE daily newsletter. Email Address The #1 Coin for November 2024 (Ad)Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… RGBP Media Mentions By Week RGBP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGBP News Sentiment▼0.000.60▲Average Medical News Sentiment RGBP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGBP Articles This Week▼00▲RGBP Articles Average Week Get Regen BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RGBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Alvotech News Today American Premium Mining News Today Anew Medical News Today Arno Therapeutics News Today AstraZeneca News Today AVVAA World Health Care Products News Today biote News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RGBP) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regen BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regen BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
